Brandywine Managers, LLC Ionis Pharmaceuticals Inc Transaction History

Brandywine Managers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $47,492 - $64,968	1,375 Added 19.41%	8,460 $337,000
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $301,183 - $451,881	7,085 New	7,085 $319,000
Q2 2019 Aug 13, 2019	SELL	$62.09 - $86.14 $155,225 - $215,350	-2,500 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $132,300 - $202,925	2,500 New	2,500 $203,000

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Managers, LLC with notifications on news.